2.要約四半期連結財務諸表及び主な注記

(1)要約四半期連結財政状態計算書

 

 

 

(単位:百万円)

 

前連結会計年度

(2024年12月31日)

 

当第3四半期連結会計期間

(2025年9月30日)

資産

 

 

 

非流動資産

 

 

 

有形固定資産

5,696

 

5,346

使用権資産

1,559

 

1,810

のれん

15,994

 

15,071

無形資産

11,026

 

11,694

持分法で会計処理されている投資

386

 

350

繰延税金資産

2,234

 

2,138

その他の金融資産

5,764

 

4,957

その他の非流動資産

56

 

73

非流動資産合計

42,720

 

41,442

 

 

 

 

流動資産

 

 

 

棚卸資産

2,529

 

3,811

営業債権及びその他の債権

6,236

 

6,061

その他の金融資産

9,291

 

7,662

その他の流動資産

1,050

 

842

現金及び現金同等物

10,115

 

22,777

流動資産合計

29,222

 

41,155

資産合計

71,942

 

82,597

 

 

 

 

負債及び資本

 

 

 

非流動負債

 

 

 

借入金

1,200

 

900

リース負債

735

 

975

繰延税金負債

2,171

 

2,141

その他の金融負債

15,454

 

15,620

その他の非流動負債

203

 

395

非流動負債合計

19,764

 

20,032

 

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

2,263

 

1,982

借入金

4,575

 

2,350

1年内返済予定の長期借入金

400

 

400

リース負債

295

 

348

未払法人所得税

2,611

 

2,734

その他の金融負債

0

 

2

その他の流動負債

2,318

 

2,215

流動負債合計

12,464

 

10,033

負債合計

32,229

 

30,066

 

 

 

 

資本

 

 

 

資本金

13,276

 

19,638

資本剰余金

6,626

 

15,659

自己株式

15

 

15

利益剰余金

9,888

 

9,393

その他の資本の構成要素

6,669

 

5,374

親会社の所有者に帰属する持分合計

36,446

 

50,050

非支配持分

3,267

 

2,481

資本合計

39,713

 

52,531

資本及び負債の合計

71,942

 

82,597

 

E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2025-01-012025-09-30Q32025-12-312024-01-012024-09-302024-12-311falsefalsefalse216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-12-31jpigp_cor:ShareCapitalIFRSMember216002024-12-31jpigp_cor:CapitalSurplusIFRSMember216002024-12-31jpigp_cor:TreasurySharesIFRSMember216002024-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-12-31jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-09-30jpigp_cor:TreasurySharesIFRSMember216002025-09-30jpigp_cor:RetainedEarningsIFRSMember216002025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-09-30jpcrp_cor:ReportableSegmentsMember216002024-01-012024-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002025-01-012025-09-30jpcrp_cor:ReportableSegmentsMember216002025-01-012025-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002025-01-012025-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002023-12-31216002024-12-31216002024-01-012024-09-30216002024-09-30216002025-01-012025-09-30216002025-09-30216002025-11-14216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002025-01-012025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-01-012025-09-30jpigp_cor:ShareCapitalIFRSMember216002025-01-012025-09-30jpigp_cor:CapitalSurplusIFRSMember216002025-01-012025-09-30jpigp_cor:TreasurySharesIFRSMember216002025-01-012025-09-30jpigp_cor:RetainedEarningsIFRSMember216002025-01-012025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002025-01-012025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002025-01-012025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002025-01-012025-09-30jpigp_cor:NonControllingInterestsIFRSMember216002025-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002025-09-30jpigp_cor:ShareCapitalIFRSMember216002025-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMemberiso4217:JPYxbrli:pureiso4217:JPYxbrli:shares